KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Ginkgo Bioworks Holdings (DNA) Leases (2020 - 2025)

Ginkgo Bioworks Holdings' Leases history spans 6 years, with the latest figure at $360.9 million for Q4 2025.

  • For Q4 2025, Leases fell 8.5% year-over-year to $360.9 million; the TTM value through Dec 2025 reached $360.9 million, down 8.5%, while the annual FY2025 figure was $360.9 million, 8.5% down from the prior year.
  • Leases reached $360.9 million in Q4 2025 per DNA's latest filing, down from $368.2 million in the prior quarter.
  • In the past five years, Leases ranged from a high of $418.0 million in Q2 2024 to a low of $4.1 million in Q4 2021.
  • Average Leases over 5 years is $332.9 million, with a median of $379.6 million recorded in 2025.
  • Peak YoY movement for Leases: surged 9674.68% in 2022, then plummeted 48.4% in 2023.
  • A 5-year view of Leases shows it stood at $4.1 million in 2021, then soared by 9674.68% to $400.8 million in 2022, then crashed by 48.4% to $206.8 million in 2023, then skyrocketed by 90.73% to $394.4 million in 2024, then fell by 8.5% to $360.9 million in 2025.
  • Per Business Quant, the three most recent readings for DNA's Leases are $360.9 million (Q4 2025), $368.2 million (Q3 2025), and $375.8 million (Q2 2025).